Advocacy, Cannabinoids, Data and Patients

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

MAY 26, 2022

Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy.

Advocacy

Advocacy Patients Clinical Trials Education

States That Restrict MMJ Access Are Interfering With Patients’ Rights, Study Shows

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access

Access Patients Chronic Pain Conditions

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS.

Cannabinoids

Cannabinoids Data Chronic Pain Sleep

NORML Publish Book Summarizing Hundreds of Studies Assessing the Safety and Efficacy of Cannabis for Patients ….Now Available on Kindle

Cannabis Law Report

NOVEMBER 2, 2021

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.

Safety

Safety Patients Chronic Pain Advocacy

Aurora Launches New Product Line in UK

Cannabis Law Report

MAY 12, 2022

Aurora Cannabis announced today that they will be launching a new product line for patients in the United Kingdom. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes

Terpenes Extraction Advocacy Patients

Virginia, Marijuana, and How Medical Legalization May Unfold in the South

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana

Marijuana Legalization Programs Oil

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

MMJ Recs

MARCH 16, 2024

Key factors influencing market size and revenue include patient demographics, regulatory frameworks, product offerings, and pricing strategies. Moreover, ensuring product quality and safety throughout the supply chain is paramount to maintain patient trust and regulatory compliance.

Supply Chain

Supply Chain Research and Development Marijuana Seed-To-Sale

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We Hemp Roundtable, the hemp industry’s national advocacy organization. “The

Safety

Safety Hemp Research and Development Data

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Cannabis Law Report

FEBRUARY 2, 2022

As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. Alternative tests, such as the LuciX platform from Dutch company Bloonics, are able to provide detailed information about the cannabinoids present in someone’s system, including synthetic cannabinoids. “We

Medicine

Medicine Clinical Trials Consumption Sleep

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Can Cannabis Improve Patient Experience Post-Surgery?” . Program between St. Vaibhav Duggal . School: Texas A&M University .

Research and Development

Research and Development Education Agriculture Patients

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We Hemp Roundtable, the hemp industry’s national advocacy organization. “The

Safety

Safety Hemp Research and Development Data

7 Medical Cannabis Organizations That Normalize Treatment

Peninsula Alternative Health

MARCH 1, 2018

The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients. ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change.

Treatment

Treatment Education Advocacy Access

7 Medical Cannabis Organizations That Normalize Treatment

Peninsula Alternative Health

MARCH 1, 2018

The common mission of these nonprofits and trade associations is to educate on the benefits of medical cannabis and create legislative change for businesses, physicians, and qualifying patients. ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change.

Treatment

Treatment Education Advocacy Access

Cannabis and traumatic brain injury, with Nikki Lawley

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Nikki’s story is deeply inspirational, and we are honored to have had her on the show.

Patients

Patients Compliance Compliance Cannabis

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. 2016 ; Sznitman et al. years (Atakan 2012 ).

Research and Development

Research and Development Medicine Access Media

Meet the Creators of Separating the Strains

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains

Strains Epilepsy Advocacy Medicine

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. Healing Advocacy Fund. Brian Muraresku. in/andrew-chadeayne-989b751/ [link]. Sam Chapman. in/sam-chapman-0a0a8229/ [link]. James Keim.

Research and Development

Research and Development Medicine Treatment Pharmaceutical

Medical Cannabis Brief

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

States That Restrict MMJ Access Are Interfering With Patients’ Rights, Study Shows

Trending Sources

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

NORML Publish Book Summarizing Hundreds of Studies Assessing the Safety and Efficacy of Cannabis for Patients ….Now Available on Kindle

Aurora Launches New Product Line in UK

Virginia, Marijuana, and How Medical Legalization May Unfold in the South

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

7 Medical Cannabis Organizations That Normalize Treatment

7 Medical Cannabis Organizations That Normalize Treatment

Cannabis and traumatic brain injury, with Nikki Lawley

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Meet the Creators of Separating the Strains

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Stay Connected